Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
      Google Scholar   
Citation:
J. Natl. Cancer Inst. vol 99 (9) 672-9
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
CA-25224, CA-35090, CA-35101, CA-35103, CA-35113, CA-35119, CA-35195, CA-35267, CA-35269, CA-35415, CA-35431, CA-35448, CA-37417, CA-52352, CA-60276, CA-63848, CA-63849, U-10 CA-37404  
Corr. Author:
 
Authors:
                         
Primary Study
NCCTG-N02C3
Secondary Studies:
Phases:
3
Keywords:
Administration, Cutaneous, Adult, Aged, Female, Humans, Interviews as Topic, Libido, Middle Aged, Neoplasms, Placebos, Sexual Behavior, Surveys and Questionnaires, Survivors, Testosterone, Treatment Outcome